Senior Vice President of Finance · Opus Genetics, Inc. (IRD)

Amy Rabourn

A named executive officer of Opus Genetics in every fiscal year CompBrief holds from FY2020 to FY2023. Every figure below is printed as the company filed it and cited to the filing it came from.

Total disclosed compensation, FY2023

$789,918

Salary $305,000Stock awards $163,128

FY2022: $499,267

6th of 6 named executive officers at Opus Genetics by FY2023 total.

6 named officers on file for Opus Genetics, FY2023

Amy Rabourn’s pay file — $29

  • 4 fiscal years of pay, line by line
  • IRD’s disclosed peer group of 10 companies

A PDF and a CSV sent to your email. Every row is cited to its filing.

One-time report. No refunds.

See an example →

Velarion Intel · free for 3 days · no card

See how Opus Genetics’s whole pay program stands against its peers

  • Opus Genetics’s company dashboard and its AI-written, board-ready brief, every figure cited to the filing
  • Peer-group intelligence, custom peer reruns and governance screens
  • Every other company we cover, with alerts when they file
Start my free trial on IRD→

No card. Nothing is charged, and the trial ends on its own.

Compensation figures as of the proxy filed April 29, 2024 (DEF 14A).

Free

Get Amy Rabourn’s pay history as a PDF, right here and by email

The PDF adds what this page leaves out: up to 10 years of pay, a peer comparison, and the board on one page. Two emails at most, nothing else.

Amy Rabourn compensation by year

Opus Genetics Summary Compensation Table · all 4 fiscal years held
In US dollars, as Opus Genetics reports it. Most recent year shaded. Totals are the company’s disclosed totals.
ComponentFY2020FY2021FY2022FY2023
Salary$33,333$240,000$260,000$305,000
Bonus$10,000$0$0$0
Stock awards$0$0$0$163,128
Option awards$213,623$0$114,751$192,690
Non-equity incentive$9,700$67,680$91,000$115,900
Pension and deferred compensation$0$0$0$0
All other$0$24,413$33,516$13,200
Total$266,656$332,093$499,267$789,918

Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: Opus Genetics, Inc. DEF 14A filed April 29, 2024, accession 0001140361-24-023004, and prior-year filings. Open the filing on EDGAR.

How this page was built: the Opus Genetics, Inc. filed document, accession 0001140361-24-023004. Every figure is read from that document and cited to the page and table it appears in. Filed April 29, 2024.

$267K
$332K
$499K
$790K
FY20
FY21
FY22
FY23
SalaryBonusNon-equity incentiveStock awardsOption awardsAll other

Equity holdings

unvested awards at FY2023 year-end
TypeUnvested unitsValue at year-endExercise price
RSU46,608$140,290—
Option69,912—$3.50
Option26,049—$2.90
Option15,644—$4.05

Per the Outstanding Equity Awards at Fiscal Year-End table in Opus Genetics, Inc.'s FY2023 proxy; value at the fiscal year-end close, as the company printed it.

Opus Genetics’s named executive officers, FY2023

as the company reported each
Named executive officerRoleFY2023 total
Mina SoochFormer Chief Executive Officer and President$2,811,138
George MagrathChief Executive Officer$2,667,353
Ronil PatelChief Business Officer$1,102,364
Richard RodgersDirector and Former Interim Chief Executive Officer and President$899,076
Bernhard HoffmannSenior Vice President of Corporate Development$789,918
Amy Rabourn · this pageSenior Vice President of Finance$789,918

The full Opus Genetics compensation record

free company brief

This page is one person within Opus Genetics's record. The company brief lists every named executive, each linking to their own page.

Peer companies

named in the Opus Genetics proxy · each links to its own free brief

Compensation, the day it’s disclosed

The CompBrief Daily Digest lists the newest executive and director compensation disclosures as companies file them.

How this record is built

Every figure on this page is one figure from a public SEC filing, printed as the filing states it and cited to the document. Compensation totals are Opus Genetics's own disclosed totals, not summed by Velarion. Insider transactions are read from Form 4 filings and cover every line filed since the most recent proxy. Nothing is estimated by Velarion; where the company does not disclose a value the cell reads "—", and a section appears only where the company discloses the data. Corrections: records@velarion.ai.

Amy Rabourn's compensation dossier · One-time report. No refunds.